UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: December 31, 2015

 

OR

 

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission File No. 000-55382

 

MICROPHASE CORPORATION

(Exact name of registrant as specified in its charter)

 

Connecticut		06-0710848
(State or other jurisdiction of incorporation)		(IRS Employer Identification No.)

 

100 Trap Falls Road Extension, Suite 400

Shelton, CT 06484

(Address of principal executive offices)

 

(203) 866-8000

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months, and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (Sec. 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.   Yes x  No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer	¨	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ¨  No x

 

As of February 16, 2016, there were 5,696,039 shares outstanding of the registrant’s common stock.

 

  

MICROPHASE CORPORATION

 

INDEX

 

		PAGE
PART I	FINANCIAL INFORMATION
Item 1	Consolidated Balance Sheets December 31, 2015 (Unaudited) and June 30, 2015	F-1
	Unaudited Consolidated Statements of Operations — Three Months Ended December 31, 2015 and 2014	F-2
	Unaudited Consolidated Statements of Operations — Six Months Ended December 31, 2015 and 2014	F-3
	Unaudited Consolidated Statements of Comprehensive Income (Loss) — Three Months Ended December 31, 2015 and 2014	F-4
	Unaudited Consolidated Statements of Comprehensive Income (Loss) — Six Months Ended December 31, 2015 and 2014	F-5
	Unaudited Consolidated Statement of Changes in Stockholders’ Deficit — Six Months Ended December 31, 2015	F-6
	Unaudited Consolidated Statements of Cash Flow — Six Months Ended December 31, 2015 and 2014	F-7
	Notes to Consolidated Financial Statements (Unaudited)	F-8 - F-18
Item 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2
Item 3	Quantitative and Qualitative Disclosures about Market Risk	9
Item 4	Controls and Procedures	9
PART II	OTHER INFORMATION
Item 1.	Legal Proceedings	10
Item 1A.	Risk Factors	10
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	10
Item 3.	Defaults Upon Senior Securities	11
Item 4.	(Removed and Reserved)	11
Item 5.	Other Information	11
Item 6	Exhibits and Reports on Form 8-K	11
	Signature Page	12

 

 

  

MICROPHASE CORPORATION

 

Consolidated Balance Sheets

 

		December 31,				June 30,
		2015				2015
		(unaudited)
ASSETS
CURRENT ASSETS
Cash and cash equivalents		$	263,573			$	127,093
Accounts receivable, net of allowance of $5,000 on December 31, 2015 and June 30, 2015			1,012,859				881,221
Inventory			792,779				852,015
Due from related parties			32,545				28,045
Prepaid and other current assets			40,084				38,906
TOTAL CURRENT ASSETS			2,141,840				1,927,280
Property and equipment, net			202,407				194,160
OTHER ASSETS
Cash – restricted			100,000				100,000
Intangible assets			466,500				474,255
Investments			182,000				200,000
Other assets			43,479				43,479
TOTAL OTHER ASSETS			791,979				817,734
TOTAL ASSETS		$	3,136,226			$	2,939,174
LIABILITIES AND STOCKHOLDERS’ DEFICIT
CURRENT LIABILITIES
Credit Facility – Revolving Loan		$	1,179,800			$	1,013,406
Accounts payable			293,840				421,915
Accrued expenses			1,109,217				1,105,943
Notes Payable – Related Parties, current portion			140,652				169,447
Asset Acquisition Note(s) Payable			300,000				300,000
Equity Lines of Credit-current portion			37,659				351,997
Other termed debts – current portion			19,848				32,654
TOTAL CURRENT LIABILITIES			3,081,016				3,395,362
Other termed debts, net of current portion			31,503				40,689
Notes Payable – Related Parties, net of current portion			310,119				290,799
Equity Lines of Credit, net of current portion			296,158				-
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ DEFICIT
6% cumulative preferred stock, $100 par value, 200,000 shares authorized, 15,382 and 26,943 shares issued and outstanding on December 31, 2015 and June 30, 2015, respectively			1,538,200				2,694,300
Common stock, no par value 7,800,000 shares authorized, 5,696,039 and 4,775,306 shares issued and outstanding at December 31, 2015 and June 30, 2015, respectively			8,432,633				6,976,533
Additional Paid In Capital			2,432,111				2,396,711
Accumulated other comprehensive loss			(18,000	)			-
Accumulated Deficit			(12,967,514	)			(12,855,220	)
TOTAL STOCKHOLDERS’ DEFICIT			(582,570	)			(787,676	)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT		$	3,136,226			$	2,939,174

 

The accompanying notes are an integral part of these consolidated financial statements.

 

  

MICROPHASE CORPORATION

 

Consolidated Statements of Operations

(unaudited)

 

		For The Three Months Ended
		December 31,
		2015				2014
Revenues		$	2,598,219			$	1,849,895
Cost of Sales			1,347,348				1,138,463
Gross Profit			1,250,871				711,432
Selling, General and Administrative Expenses (including non-cash stock related charges of $335,400 and $630,000 for the three months ended December 31, 2015 and 2014)			1,067,780				1,234,908
Engineering and Research expenses (including non-cash stock related charges of $0 and $80,000 for the three months ended December 31, 2015 and 2014)			261,150				293,386
Non-operating Expense			(6,018	)			(1,232	)
Interest (Expense and Credit costs) net			(59,287	)			(56,901	)
(Loss) on Settlement of Liabilities (including $218,836, loss on settlement of liabilities with related parties)			-				(223,866	)
Loss From Operations, before Income Tax Expense			(143,364	)			(1,098,861	)
Income Tax Expense			(39,317	)			(250	)
Net Loss		$	(182,681	)		$	(1,099,111	)
Preferred dividends declared and settled in common stock, including $164,913 loss on settlement of dividend payable			-				(659,649	)
Net Loss available to common shareholders		$	(182,681	)		$	(1,758,760	)
Basic & Diluted Net Loss per share:		$	(0.04	)		$	(0.45	)
Weighted Average Number of Shares Outstanding:
Basic & Diluted			4,935,433				3,930,679

 

The accompanying notes are an integral part of these consolidated financial statements.

 

  

MICROPHASE CORPORATION

 

Consolidated Statements of Operations

(unaudited)

 

		For The Six Months Ended
		December 31,
		2015				2014
Revenues		$	5,050,074			$	3,779,078
Cost of Sales			2,762,531				2,243,518
Gross Profit			2,287,543				1,535,560
Selling, General and Administrative Expenses (including non-cash stock related charges of $335,400 and $630,000 for the six months ended December 31, 2015 and 2014)			1,770,780				1,918,138
Engineering and Research expenses (including non-cash stock related charges of $0 and $80,000 for the six months ended December 31, 2015 and 2014)			467,464				500,629
Non-operating Income (Loss)			(3,768	)			1,018
Interest (Expense and Credit costs) net			(117,458	)			(119,589	)
(Loss) on Settlement of Liabilities (including $218,836, loss on settlement of liabilities with related parties)			-				(223,866	)
Loss From Operations, before Income Tax Expense			(71,927	)			(1,225,644	)
Income Tax Expense			(40,367	)			(250	)
Net Income Loss		$	(112,294	)		$	(1,225,894	)
Preferred dividends declared and settled in common stock, including $164,913 loss on settlement of dividend payable			-				(659,649	)
Net Loss available to common shareholders		$	(112,294	)		$	(1,885,543	)
Basic & Diluted Net Loss per share:		$	(0.02	)		$	(0.52	)
Weighted Average Number of Shares Outstanding:
Basic & Diluted			4,856,250				3,592,142

 

The accompanying notes are an integral part of these consolidated financial statements.

 

  

MICROPHASE CORPORATION

 

Consolidated Statements of Comprehensive Income (Loss)

(unaudited)

 

		For The Three Months Ended
		December 31,
		2015				2014
Net Loss		$	(182,681	)		$	(1,099,111	)
Other comprehensive income (loss):
Net unrealized gain (loss) on securities available-for-sale, net of income taxes			19,067				(29,466	)
Total comprehensive income (loss)		$	(163,614	)		$	(1,128,577	)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

  

MICROPHASE CORPORATION

 

Consolidated Statements of Comprehensive Income (Loss)

(unaudited)

 

		For The Six Months Ended
		December 31,
		2015				2014
		(unaudited)				(unaudited)
Net Loss		$	(112,294	)		$	(1,225,894	)
Other comprehensive income (loss):
Net unrealized gain (loss) on securities available-for-sale, net of income taxes			(18,000	)			(48,333	)
Total comprehensive income (loss)		$	(130,294	)		$	(1,274,227	)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

  

MICROPHASE CORPORATION

 

Statement of Changes in Stockholders’ Deficit

For the Six Months ended December 31, 2015

(unaudited)

 

		Preferred Stock								Common Stock								Additional Paid				Accumulated Other Comprehensive				Accumulated
		Shares				Amount				Shares				Amount				In Capital				Loss				Deficit				Amount
Balance, June 30, 2015			26,943			$	2,694,300				4,775,306			$	6,976,533			$	2,396,711			$	-			$	(12,855,220	)		$	(787,676	)
Unrealized investment loss during the Six Months Ended December 31, 2015																							(18,000	)							(18,000	)
Issuance of common stock and options for services											150,000				300,000				35,400												335,400
Conversion of preferred stock into Common Stock			(11,561	)			(1,156,100	)			770,733				1,156,100				-								-				-
Net (Loss) For the Six Months Ended December 31, 2015																											(112,294	)			(112,294	)
Balance, December 31, 2015			15,382			$	1,538,200				5,696,039			$	8,432,633			$	2,432,111			$	(18,000	)		$	(12,967,514	)		$	(582,570	)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

MICROPHASE CORPORATION

 

Consolidated Statements of Cash Flows

(unaudited)

 

		For The Six Months Ended
		December 31,
		2015				2014
Cash Flow From Operating Activities:
Net Loss		$	(112,294	)		$	(1,225,894	)
Adjustments to reconcile net (loss) to net cash provided by operating activities:
Depreciation and amortization			46,710				44,929
Non-cash charges relating to issuance of common stock for services			335,400				933,866
Increase (decrease) in allowance for doubtful accounts and inventory reserve			-				8,830
(Gain) on sale of equipment			-				(2,275	)
Changes in assets and liabilities:
Accounts receivable			(131,638	)			321,835
Inventories			59,236				5,805
Other current assets			(1,178	)			47,202
Accounts payable			(128,075	)			(4,685	)
Accrued expenses			13,180				92,248
Customer deposits			-				(89,634	)
Due to/from related parties mPhase & Edson Realty			(4,500	)			2,219
Officers wages			-				(29,750	)
Net cash provided by operating activities		$	76,841			$	104,696
Cash Flow (used in ) Investing Activities:
Investments in common stock			-				(200,000	)
Purchase of intangible assets			-				(50,000	)
(Purchase of) proceeds from-fixed assets			(47,202	)			2,275
Net Cash (used in) investing activities		$	(47,202	)		$	(247,725	)
Cash Flow provided by (used in) Financing Activities:
Proceeds from issuance of common stock			-				354,550
Proceeds (Repayment) from credit facility, net			166,394				(132,936	)
Payments of equity lines of credit			(18,180	)			(3,576	)
Payments of long-term debt			(12,742	)			(925	)
Payments on acquisition notes			-				(360,000	)
Payments of capital lease obligations			(5,264	)			(9,722	)
Payments to related parties			(19,381	)			(97,486	)
Payments of extended term arrangement			(3,986	)			(3,795	)
Net cash provided by (used in) financing activities		$	106,841			$	(253,890	)
Net increase (decrease) in cash		$	136,480			$	(396,919	)
CASH AND CASH EQUIVALENTS, beginning of period		$	127,093			$	445,080
CASH AND CASH EQUIVALENTS, end of period		$	263,573			$	48,161

 

The accompanying notes are an integral part of these consolidated financial statements.

 

  

MICROPHASE CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

NOTE 1 — BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

NATURE OF OPERATIONS

 

Microphase Corporation (the “Company”) is a design to manufacture original equipment manufacturer (OEM) industry leader delivering world-class radio frequency (RF) and microwave filters, diplexers, multiplexers, detectors, switch filters, integrated assemblies and detector logarithmic video Amplifiers (DLVA) to the military, aerospace and telecommunications industries. Sales to military markets represent 100% of sales. The Company has two manufacturing facilities, one in Shelton, Connecticut and one in Folsom, California.

 

BASIS OF PRESENTATION

 

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and pursuant to the regulations of the Securities Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three and six months ending December 31, 2015 are not necessarily indicative of the results that may be expected for a full fiscal year. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company’s Annual Report on Form 10-K for the year ended June 30, 2015. As of June 30, 2015, we had an accumulated deficit of $12,855,220 and a total stockholders’ deficit of $787,676. As of December 31, 2015, we had an accumulated deficit of $12,967,514 (unaudited) and a total stockholders’ deficit of $582,570 (unaudited). A significant amount of capital will be necessary to sustain, grow and advance our business and these conditions raise substantial doubt about our ability to continue as a going concern, as expressed in our Auditor’s report for the years ended June 30, 2015 and 2014.

 

The Company’s ability to continue as a going concern and its future success is dependent upon its ability to raise capital in the near term to: (1) satisfy its current obligations, (2) continue its research and development efforts, and (3) allow the successful wide scale development, deployment and marketing of its products.

 

PROPERTY AND EQUIPMENT — Are stated at cost. Provision for depreciation and amortization for financial reporting and income tax purposes is made by annual charges to operations principally under the following methods and estimated useful lives:

 

		Method		Years
Leasehold Improvements		Straight Line		7
Property held under capital leases		Straight Line		5
Furniture and fixtures		Straight Line		7
Machinery and equipment		Straight Line		5
Computer equipment		Straight Line		3
Transportation equipment		Straight Line		5

 

MAINTENANCE AND REPAIRS— Charged to expenses as incurred. Cost of major replacements and renewals are capitalized. Upon retirement or other disposition of equipment and improvements, the cost and related depreciation is removed from the accounts, and any gain or loss is recognized in income.

 

INVENTORIES — are stated at the lower of average cost or market under the first-in, first-out method. The Company regularly reviews inventory quantities on hand and records a provision for excess and obsolete inventory primarily based on our estimated forecast of product demand, anticipated end of product life and production requirements.

 

  

OTHER LONG LIVED ASSETS — The Company reviews long-term assets for impairment whenever events or circumstances indicate that the carrying amount of those assets may not be recoverable. The Exclusive License associated with the Microsemi Inc. (“Microsemi”) asset acquisition was valued at $56,861, was ascribed a perpetual life and is subject to evaluation annually for impairment. The Exclusive License associated with the Dynamac Strategic agreement discussed below in Note 13 will be valued at the contract price, has an unlimited contractual life, and is also subject to evaluation annually for impairment. The Company also assesses these assets for impairment based on their future cash flows. Management has determined that there was no impairment charge to be recorded for the year ended June 30, 2015 and the six months ended December 31, 2015. The Customer Lists and Non-Compete agreements associated with the Microsemi asset acquisition were ascribed useful lives of 7 and 5 years respectively. Amortization expense recorded for these intangible assets was $3,878 and $7,755 and $3,878 and $7,755 for the three and six months ended December 31, 2015 and 2014, respectively.

 

ACCOUNTS RECEIVABLE — Management records receivables at net realizable value and they generally do not bear interest. This value includes an allowance for estimated uncollectible accounts to reflect any loss anticipated on the accounts receivable balances which is charged to the provision for doubtful accounts. We calculate this allowance based on our history of write-offs, level of past due accounts and economic status of the customers. We consider a receivable delinquent if it is unpaid after 180 days after it is due.

 

ACCOUNTING ESTIMATES — Management uses estimates and assumptions in preparing financial statements in accordance with generally accepted accounting principles. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Actual results could vary from the estimates that were assumed in preparing the financial statements.

 

COMPENSATED ABSENCES — Employees of the Company are entitled to vacation pay depending on length of service and current salary. Unused vacation days are only carried over to the subsequent year under special approval by management. The Company has provided for vacation liabilities in the accompanying financial statements.

 

RESEARCH AND DEVELOPMENT EXPENSES — The Company charges the cost of research and development to operations when incurred.

 

REVENUE RECOGNITION  — As required, Microphase has adopted the SEC Staff Accounting Bulletin (“SAB”) No. 104, “Revenue Recognition in Financial Statements,” which provides guidelines on applying generally accepted accounting principles to revenue recognition based on interpretations and practices of the SEC. The Company recognizes revenue when products are shipped and title passes to the customer.

 

PRINCIPLES OF CONSOLIDATION — The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries which include Microphase West LLC, as of June 27, 2013, and Microphase Instruments, LLC, as of October 23, 2015. All intercompany accounts and transactions have been eliminated.

 

EARNINGS (LOSS) PER SHARE — Basic earnings (loss) per share (“EPS”) is determined by dividing the net earnings (loss) by the weighted-average number of shares of common shares outstanding during the period. Diluted EPS is determined by dividing net earnings (loss) by the weighted average number of common shares used in the basic EPS calculation plus the number of common shares that would be issued assuming conversion of all potentially dilutive securities (such as stock options, preferred stock subsequent to October 4, 2014, and convertible securities) outstanding under the treasury stock method. On October 4, 2014 the shareholders approved a convertible feature in preferred stock, such preferred stock at par value convertible into common shares at agreed upon market value.

 

  

RECENT ACCOUNTING PRONOUNCEMENTS—The Company is evaluating several pronouncements issued by the FASB which may result in the adoption by the Company of these standards in upcoming accounting periods as follows:

 

On April 7, 2015, the FASB issued Accounting Standards Update 2015-03, Interest—Imputation of Interest (Subtopic 835-30): Simplifying the Presentation of Debt Issuance Costs, which requires entities to present debt issuance costs related to a recognized debt liability as a direct deduction from the carrying amount of that debt liability. The guidance in Update 2015-03 (see below) does not address presentation or subsequent measurement of debt issuance costs related to line-of-credit arrangements. Given the absence of authoritative guidance within Update 2015-03 for debt issuance costs related to line-of-credit arrangements, the SEC staff would not object to an entity deferring and presenting debt issuance costs as an asset and subsequently amortizing the deferred debt issuance costs ratably over the term of the line-of-credit arrangement, regardless of whether there are any outstanding borrowings on the line-of-credit arrangement. to be effective for Fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015; which for us would be our fiscal 2016 and although early adoption is permitted for this standard, the Company has not adopted nor determined its applicability.

 

On August 27, 2014, the FASB issued ASU 2014-15, which provides guidance on determining when and how to disclose going-concern uncertainties in the financial statements. The new standard requires management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. An entity must provide certain disclosures if “conditions or events raise substantial doubt about [the] entity’s ability to continue as a going concern.” The ASU applies to all entities and is effective for annual periods ending after December 15, 2016, and interim periods thereafter, with early adoption permitted; which for us would be our fiscal 2017 and although early adoption is permitted for this standard, the Company has not adopted nor determined its applicability.

 

On July 22, 2015, the FASB issued ASU 2015-11, which requires entities to measure most inventory “at the lower of cost and net realizable value,” thereby simplifying the current guidance under which an entity must measure inventory at the lower of cost or market (market in this context is defined as one of three different measures). The ASU will not apply to inventories that are measured by using either the last-in, first-out (LIFO) method or the retail inventory method (RIM). For public business entities, the ASU is effective prospectively for annual periods beginning after December 15, 2016, and interim periods therein. For all other entities, the ASU is effective prospectively for annual periods beginning after December 15, 2016, and interim periods thereafter; which for us would be our fiscal 2017 and although early adoption is permitted for this standard, the Company has not adopted nor determined its applicability. Upon transition to this ASU the Company would be required to disclose the nature of and reason for the accounting change.

 

Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date -In May 2014, the FASB issued a comprehensive new revenue recognition standard that supersedes nearly all revenue recognition guidance under U.S. GAAP and supersedes some cost guidance for construction-type and production-type contracts. The guidance in this standard is principles-based, and accordingly, entities will be required to use more judgment and make more estimates than under prior guidance, including identifying contract performance obligations, estimating variable consideration to include in the contract price and allocating the transaction price to separate performance obligations. The guidance in this standard is applicable to all contracts with customers, regardless of industry-specific or transaction-specific fact patterns. Additionally, this standard provides guidance for transactions that were not previously addressed comprehensively (e.g., service revenue, contract modifications and licenses of intellectual property) and modifies guidance for multiple-element arrangements. The core principle of this standard is that entities should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. To help financial statement users better understand the nature, amount, timing and potential uncertainty of the revenue that is recognized, this standard requires significantly more interim and annual disclosures. This standard allows for either “full retrospective” adoption (application to all periods presented) or “modified retrospective” adoption (application to only the most current period presented in the financial statements, as well as certain additional required footnote disclosures). On July 9, 2015, the FASB approved a one-year deferral of the effective date, while permitting entities to elect to adopt one year earlier on the original effective date. As a result, this standard is now effective for fiscal years, and interim reporting periods within those years, beginning after December 15, 2017, which for us is our fiscal 2019. We are currently evaluating the impact this standard will have on our financial position, results of operations and cash flows.

 

  

NOTE 2 — SUPPLEMENTAL CASH FLOW INFORMATION

 

		For the six months ended
		December 31,
		2015				2014
		(Unaudited)				(Unaudited)
Statement of Operation Information:
Cash paid for income taxes		$	42,717			$	250
Interest Paid (net interest income)		$	107,552			$	72,573
Non Cash Investing and Financing Activities:
Assets acquired with debt financing		$	-			$	300,000
Conversion of $15,000 of strategic payables into common stock with beneficial conversion feature interest of $5,000		$	-			$	20,000
Conversion of $320,000 of related party loans, including $21,043 accrued interest thereon, into 213,333 shares of common stock with beneficial conversion feature interest of $106,666		$	-			$	426,666
Conversion of $180,000 of related party loans into 1,800 shares of preferred stock with beneficial conversion feature interest of $59,400		$	-			$	239,400
Conversions of $160,000 of unpaid compensation into 1,600 shares of preferred stock with beneficial conversion feature interest of $52,800		$	-			$	212,800
Preferred stock dividend, declared on preferred shares held through September 30, 2014, of $494,736 paid through the issuance of 329,825 shares of common stock with beneficial conversion feature interest of $164,913		$	-			$	659,649
Conversion of 11,516 shares of preferred stock into 770,733 shares of common stock		$	1,156,100			$	-

 

NOTE 3 — INVENTORIES CONSIST OF THE FOLLOWING:

 

		December 31, 2015
		(unaudited)				June 30, 2015
Raw materials		$	446,968			$	402,761
Work-in-process			382,811				486,254
Reserve			(37,000	)			(37,000	)
Total		$	792,779			$	852,015

 

The inventory reserve was increased by $25,000 in our west division and reduced by $10,000 in our east division during the year ended June 30, 2015. No changes were made to the inventory reserve for the six months ended December 31, 2015.

 

  

NOTE 4 — PROPERTY AND EQUIPMENT:

 

Property and equipment was comprised of the following:

 

		December 31, 2015
		(unaudited)				June 30, 2015
Leasehold Improvements		$	40,288			$	8,290
Computers, machinery & equipment			3,210,147				3,194,943
Furniture and fixtures			122,350				122,350
Transportation equipment			40,438				40,438
Property held under capital leases			56,013				56,013
			3,469,236				3,422,034
Less: accumulated depreciation and amortization			(3,266,829	)			(3,227,874	)
Total		$	202,407			$	194,160

 

Depreciation expense was $19,566 and $18,499 during the three months ended December 31, 2015 and 2014, respectively.

 

Depreciation expense was $38,955 and $37,174 during the six months ended December 31, 2015 and 2014, respectively.

 

NOTE 5 — ACCRUED AND OTHER EXPENSES:

 

Accrued expenses were comprised of the following:

  

		December 31, 2015
		(unaudited)				June 30, 2015
Salaries, wages and other compensation, including $357,815 to officers and affiliates at December 31, 2015 (unaudited) and June 30, 2015, respectively		$	706,940			$	678,729
Royalties			195,818				190,924
Professional fees			122,280				135,000
Commissions			37,936				37,936
Other miscellaneous accruals			46,243				63,354
		$	1,109,217			$	1,105,943

  

  

NOTE 6 — FAIR VALUE OF FINANCIAL INSTRUMENTS:

 

The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. Quoted market prices are used to establish fair value when they are available and other valuation techniques are utilized to estimate the fair value of financial instruments that do not have quoted market prices.

 

The Company has long term debt with fixed interest rates, the carrying amount of which may be different from fair value as of December 31, 2015 and June 30, 2015. The Company decided that it is not practical to estimate the fair value of these financial instruments on the basis that they are held-to-maturity debts which have no immediately available market information on the fair value and the cost of making assumptions and applying estimation methodologies to assess the fair value estimates exceeds the benefit. Information pertinent to estimating the fair value such as carrying amount, effective interest rate, maturity and repayment term are disclosed in Notes 7, 8, 9 & 10.

 

The Company has applied the fair value concepts to its available-for-sale securities. As such, the valuation techniques used to measure fair value is based on the source of the data used to develop the prices. The priority of these sources is defined as follows:

 

Level 1 — quoted prices in active markets.

Level 2 — other than quoted prices that are directly or indirectly observable.

Level 3 — unobservable inputs for the asset or liability.

 

Marketable securities, classified as available-for-sale securities, are measured at fair market value (Level 1) on a recurring basis as of June 30, 2015 amounted to $200,000. The amount at December 31, 2015 was $182,000.

 

NOTE 7 — REVOLVING CREDIT LINE

 

		December 31, 2015				June 30, 2015
		(unaudited)
The Company entered into a revolving loan agreement with Gerber Finance, Inc. (Gerber) in February of 2012 for a maximum of $1,500,000, which was amended to $1,150,000 in November of 2013. As of December 31, 2015 this line is negotiated to increase to $1,400,000. Under this agreement, the Company can receive funds based on a borrowing base, which consists of various percentages of accounts receivable, inventory, a restricted cash account held by Gerber, and equipment. In connection with this agreement, the Company is subject to an annual facility fee (1.75%) on each anniversary, monthly collateral monitoring fees of $1,500 and other fees, plus interest currently at the rate of 7.25%		$	1,179,800			$	1,013,406

 

The interest expense for the three months ended December 31, 2015 and 2014, respectively, was $30,055 and $22,943, and the fees for the same period ended December 31, 2015 and 2014 were $10,067 and $4,500. The interest expense for the six months ended December 31, 2015 and 2014, respectively was $57,488 and $50,943, and the fees for the same period ended December 31, 2015 and 2014 were $19,777 and $9,000. The effective annualized interest rate for the six months ended December 31, 2015 was 10.25% and for same six months in 2014 was 11.84%.

 

There are financial covenants set forth in the Gerber agreement of February 3, 2012 and as amended on February 24, 2012. The covenants, covering among other things tangible net worth and net loss, were not effective until September 30, 2012. The Company has not received notice of default since curing its financial reporting covenants in January, 2015.

 

Approximate Value of collateral at balance sheet dates —

 

		December 31, 2015				June 30, 2015
		(unaudited)
Inventories		$	792,779			$	852,015
Accounts Receivable			1,012,859				881,221
Total		$	1,805,638			$	1,733,236

 

  

NOTE 8 — EQUITY LINES OF CREDIT

 

The Company had previously guaranteed the payment under the terms of an assumption agreement, as amended, of an Equity Line of Credit with Wells Fargo Bank totaling up to $250,000, the proceeds of which the Company received from a concurrent loan from Edson Realty Inc. which was a related party-owned realty holding company at the time the credit line was funded on August 15, 2008. As of June 30, 2015, this first line of credit had $250,000 available, secured by residential real estate owned by a former COO of the Company, of which $232,466 was outstanding, with an interest rate of 3.35%. As of December 31, 2015, this line of credit has $250,000 available, of which $224,366 is outstanding, with an interest rate of 3.35%.

 

The Company charged operations $1,919 and $2,035 for interest on this line of credit in the three months ended December 31, 2015 and 2014, respectively. The Company charged operations $3,859 and $4,075 for interest on this line of credit in the six months ended December 31, 2015 and 2014, respectively.

 

Effective June 30, 2014, the Company also has guaranteed to the CEO, under the terms of an assumption agreement, as amended, the repayment of a second Equity Line of Credit with Wells Fargo Bank. The Company received working capital loans from the CEO which were from funds drawn against this Equity Line of Credit. As of June 30, 2015 the second line of credit had $150,000 available, secured by the CEO’s principal residence, of which $119,531 was outstanding, with an interest rate of 3.0%. As of December 31, 2015, this line of credit has $150,000 available, of which $109,451 is outstanding, with an interest rate of 3.00%.

 

The Company charged operations $852 and $968 for interest on this line of credit in the three months ended December 31, 2015 and 2014, respectively. The Company charged operations $1,762 and $1,973 for interest on this line of credit in the six months ended December 31, 2015 and 2014, respectively.

 

NOTE 9 — RELATED PARTY TRANSACTIONS

 

mPhase Technologies, Inc. (“mPhase”) — The Company has had, up and until February 2015, some common management and common significant shareholders with mPhase and had owned a total of 42,793,354 shares of this publicly-traded company. As of June 30, 2014, the shares were transferred to two officers at that time, the CEO and the former COO, as partial payment of working capital loans due to them by the Company; the transfer was valued at $34,235 based upon the closing trading price for these shares on that date and the Company has not held any ownership interest in mPhase since.

 

The Company sublet office space to mPhase until March 31, 2015. As of June 30, 2015, mPhase owed the Company $28,045. Rent expense was $0 and $9,525 for the quarters ended December 31, 2015 and 2014, respectively. At December 31, 2015, mPhase owed the Company $30,295.

 

Notes Payable — Related Parties:
		December 31, 2015				June 30, 2015
		(unaudited)
Officers and Stockholders:
Payable in monthly payments of $700 as revised, including interest at 3% through April, 2019, of which $180,000 was converted into 1,800 shares of preferred stock during Fiscal Year Ended June 30, 2015. The monthly payment amount increases by $100 every 4 months, per the revised schedule.		$	44,789			$	44,258
Former Employee:
Payable in monthly payments of $2,450 as revised, including interest at 3% through April, 2019 of which $170,000 was converted into 113,333 shares of common stock during Fiscal Year Ended June 30, 2015. The monthly payment amount increases by $350 every 4 months, per the revised schedule.			155,563				168,599
Stockholders:
Two notes payable to individuals with monthly payments of $910 and $980 as revised, including interest at 3% through April 2019. The monthly payment amounts increase by $130 and $140 respectively every 4 months, per the revised schedule.			122,619				121,140
Other Related Parties:
Payable in monthly payments of $280 as revised, including interest at 3% through April, 2019. The monthly payment amount increases by $40 every 4 months, per the revised schedule.			19,308				19,058
Two identical notes payable in monthly payments of $840 each as revised, including interest at 3% through April, 2019. The monthly payment amount increases by $120 every 4 months, per the revised schedule.			108,492				107,191
Total			450,771				460,246
Less: current portion			(140,652	)			(169,447	)
Long-term portion		$	310,119			$	290,799

 

The Company charged operations $5,825 and $15,160 for interest on these loans for the quarters ended December 31, 2015 and 2014, respectively. The Company charged operations $12,763 and $25,973 for interest on these loans for the six months ended December 31, 2015 and 2014, respectively.

 

The Company and the note holders have agreed to revised repayment schedules for 42 months commencing December 2015.

 

  

NOTE 10 — OTHER TERMED DEBTS

 

Other termed debts consist of: (i) Long-term Debt, (ii) Capital Leases , & (iii) Extended Payment Arrangements.

 

Long-term Debt:

 

		December 31, 2015
		(unaudited)				June 30, 2015
People's General Bank
Overdraft protection credit line loan; up to $20,000 available at June 30, 2014, with minimum payments based upon a thirty six month payout from most recent utilization, or $315.53 plus interest at June 30, 2014. Microphase paid this loan off in the 2nd quarter.		$	—			$	7,542
Ford Credit Company:
Payable in monthly payments of $499, including interest at 4.90% through April, 2019 secured by transportation equipment.		$	15,704			$	20,904
Total		$	15,704			$	28,446
Less: current portion			(5,081	)			(12,623	)
Long-term portion		$	10,623			$	15,823

 

The Company charged operations $237 and $748 in interest for these loans for the three months ended December 31, 2015 and 2014, respectively. The company charged operations $770 and $1,486 in interest for these loans for the six months ended December 31, 2015 and 2014, respectively.

 

Capital Leases:

 

The Company is the lessee of equipment under capital leases expiring through March, 2016. The assets are recorded at the fair market value as of the date of the leases. The assets are amortized over their estimated productive lives. Amortization is included in depreciation expense.

 

		December 31, 2015
		(unaudited)				June 30, 2015
The following is a summary of property held under capital leases:
Property held under capital leases		$	56,013			$	56,013
Less: accumulated amortization			(43,877	)			(38,276	)
Net property under capital leases		$	12,136			$	17,737
Minimum future lease payments under capital leases as of December 31, 2015 for the next four years are as follows:
Total minimum lease payments		$	6,950				12,510
Less: amount representing interest			(153	)			(449	)
Present value of net minimum lease payments			6,797				12,061
Less: current portion			(6,797	)			(12,061	)
Long-term portion		$	—			$	—

 

Interest expense charged to operations under capital leases was $153 and $543 for the three months ended December 31, 2015 and 2014, respectively. Year-to-date interest expense charged to operations under capital leases was $477 and $1,001 for the six months ended December 31, 2015 and 2014, respectively.

 

Extended Payment arrangements:

 

The Company is responsible for paying a former employee, disability benefits under a prior self-insured plan, through April, 2019. The plan requires monthly payments until the participant attains age 65. Interest has been imputed on this obligation at 5%.

 

		December 31, 2015				June 30, 2015
		(unaudited)
Total of extended disability benefits		$	31,436			$	36,152
Less: amount representing interest			(2,586)				(3,316)
Present value of disability benefits			28,850				32,836
Less: current portion			(7,970)				(7,970)
Long-term portion		$	20,880			$	24,866

 

Interest expense charged to operations for the extended disability payments was $378 and $474 for the three months ended December 31, 2015 and 2014, respectively. Year-to-date interest expense charged to operations for the extended disability payments was $780 and $972 for the six months ended December 31, 2015 and 2014, respectively.

 

Summary totals for Other termed debts consist of: (i) Long-term Debt, (ii) Capital Leases , & (iii) Extended Payment Arrangements.

 

		December 31, 2015
		(unaudited)				June 30, 2015
Total minimum long term debt, capital lease & extended disability payments		$	51,351			$	61,282
Less: current portion			(19,848	)			(32,654	)
Long-term portion		$	31,503			$	28,628

 

  

NOTE 11 — STOCKHOLDERS’ EQUITY:

 

Microphase Corporation has authorized capital of 7,800,000 shares of common stock (“Common Stock”) with no par value and 200,000 shares of Series A Convertible Preferred Stock (“Preferred Stock”) with $100 par value per share, with 6% cumulative dividends.

 

On October 4, 2014, at a special meeting of the shareholders of the Company, the shareholders approved amendments to the Certificate of Incorporation of the Company to: (1) Increase its authorized common stock from 4,800,000 shares of common stock without par value up to 50,000,000 shares of common stock without par value; the Board of Directors has implemented such increase to 7,800,000 shares of Common Stock; (2) increase its authorized preferred stock from 200,000 shares, $100 par value per share up to 2,000,000 shares of 6% convertible preferred stock; such increase has yet to be implemented. Each outstanding and hereafter issued share of the Preferred Stock will: i) continue to be entitled to a cash dividend, payable quarterly on the last business day of each fiscal quarter of the Company, commencing with the fiscal quarter ended December 31, 2014, if and when declared by the Company’s board of directors (the “Board”) . These dividends will be cumulative, will accrue if not declared by the Board, and must be paid before any dividends or other distributions are made to the common shareholders, be entitled, on liquidation of the Company, to receive $100 per share plus accrued dividends before any distributions are made to the common shareholders, be convertible at the option of the holder into Common Stock.

 

Common Stock

 

Effective December 31, 2014, the Company issued 355,000 shares of Common Stock to advisors, consultants and employees valued at $710,000, which was charged to operations in the quarter ending December 31, 2014.

 

Effective December 31, 2014, an officer and a former employee converted $150,000 and $170,000, respectively, or a total of $320,000 of related party loans into 213,333 shares of Common Stock. A strategic vendor converted $15,000 of accounts payable into 10,000 shares of Common Stock.

 

During the six months ended December 31, 2015, the Company issued no shares of Common Stock in private placements.

 

During the three months ended December 31, 2015 the Company issued Common Stock to two consultants pursuant to consulting agreements and to two Officers and Directors for services, in the amounts of 80,000 and 70,000, respectively, valued at $300,000, which was charged to operations in the quarter ending December 31, 2015.

 

Preferred Stock

 

The Preferred Stock, with respect to dividends, liquidation payments, and liquidation rights, ranks senior to the common stock and of the Company. Holders of Preferred Stock are entitled to receive, when and as declared by the Board of Directors, dividends, at the annual rate of 6% of the stated par value, or $100 per share. Dividends are cumulative and accrue from the effective date of issuance of the Preferred Stock until declared.

 

In December 2014, the Board declared $494,735 of dividends on preferred shares outstanding as of December 31, 2014 and authorized the payment in 329,825 shares common stock using a conversion rate of $1.50 per share, charging an additional $164,193 to retained deficit for the loss on the settlement of the dividend payable.

 

Also in December 2014 an officer converted $180,000 of related party loans into 1,800 shares of the Company’s Preferred Stock. Two officers each converted $80,000, or a total of $160,000 of unpaid compensation into a total of 1,600 shares of the Company’s preferred stock.

 

Effective December 31, 2015, the Company issued 770,733 shares of the Company’s Common Stock pursuant to the conversion of 11,561 shares of the Company’s Series A Convertible Preferred Stock (the “Preferred Stock”) held by a private investor. The issuance did not result in any proceeds to the Company as the conversion to common shares effectively cancelled 11,561 shares of Preferred Stock previously acquired by the holder.

 

As of December 31, 2015, 15,382 shares of Preferred Stock are outstanding and cumulative undeclared dividends on preferred stock are $197,263.  

 

  

Capital stock conversions

 

The Company recorded beneficial conversion feature interest of $223,866 which was charged to operations in the six months ending December 31, 2014, in connection with the conversion of $675,000 of related party debts into 233,333 shares of common stock and 3,400 shares of $100 preferred stock convertible into common stock at $1.50 per share, based upon the difference between the conversion value of $1.50 and $2.00, the value of shares issued in recent private placements.

 

Reserved Shares 

 

Stock Options 

 

The Board approved the implementation of a stock option plan in January 2015, for which the Company will not seek ratification by the shareholders, reserving 250,000 shares of Common Stock for this plan; however, such plan has not yet been set forth in a formal document adopted by the board. During the six months ended December 31, 2015 the Company granted options, as part of this plan, to an Officer and Director for services to purchase 75,000 shares of Common Stock, with an exercise price of $2.00, with a term of 7 years, and which rights vest over the next three years as follows; 25,000 shares were exercisable immediately and 25,000 shares vest each October 1 of 2016 and 2017. The total value of these options was estimated to be $106,200 using the Black Scholes method, based on an assumed volatility of 112.5% and an interest rate of .09%. $35,400 was charged to operations in the six months ending December 31, 2015 deferring the balance of which $35,400 will be charged each October 1 of 2016 and 2017.

 

Series A Preferred Shares currently convertible

 

As of December 31, 2015, 15,382 preferred shares were outstanding and cumulative undeclared dividends on preferred stock were $197,263. The preferred shares are convertible into 1,254,467 shares of the Company’s common stock at $1.50, and the dividends, if declared, are convertible into 131,509 common shares stock also at $1.50, until such time the Company’s common stock begins trading.  

 

Certain Debts currently convertible

 

$450,771 of loans from related parties and $357,815 of unpaid compensation are convertible into 300,514 and 238,543 shares of the Company’s common stock at $1.50, respectively, until such time the Company’s common stock begins trading.  

 

Deferred Common Stock Awards

 

The Board approved additional stock compensation for the Company’s Chief Financial Officer and a Director of the Company and the Company’s Chief Technology Officer, Chief Marketing Officer, and a Director of the Company whereby they will receive an additional 100,000 and 175,000 shares of common stock each as follows: 30,000 and 40,000 shares per quarter for the next three quarters, beginning December 31, 2015, and then 10,000 and 55,000 shares in the quarter ending September 30, 2016.

 

NOTE 12 — MAJOR CUSTOMERS AND SEGMENTS:

 

The Company had two customers during the year ended June 30, 2015 which each accounted for more than 10% of sales.

 

The Company recorded sales of $3,689,132 with the two customers during the year ended 2015. These sales represented 45% of total sales for the fiscal year. At June 30, 2015 these customers owed $383,464 to the Company.

 

The Company recorded sales of $1,645,957 and $855,168, with four and two customers, for the three months ended December 31, 2015 and 2014, respectively. These sales represent 63% and 46% of sales for the three months ended December 31, 2015 and 2014, respectively.

 

The Company recorded sales of $2,751,273 and $1,854,941, with three and three customers, for the six months ended December 31, 2015 and 2014, respectively. These sales represent 55% and 49% of sales for the six months ended December 31, 2015 and 2014, respectively. At December 31, 2015, those 3 customers owed the Company $322,280.

 

Sales to U.S. customers represented 86% of sales in fiscal 2015. Sales to U.S. customers were $2,090,786 and $1,588,444 which represented 86% and 88% of sales for the three months ended December 31, 2015 and 2014, respectively. Sales to U.S. customers were $4,201,274 and $3,268,096 which represented 83% and 86% of sales for the six months ended December 31, 2015 and 2014, respectively.

 

NOTE 13 — COMMITMENTS AND CONTINGENCIES:

 

In connection with the Microsemi acquisition, the Company signed a lease for 4,000 square feet of space at Microsemi’s facility in Folsom, CA. The commitment for fiscal 2014 was $75,600. The lease was renegotiated in April 2014 with a new rent of $7,000 per month beginning in June 2014. The lease was renegotiated again in February 2015 with new rent of $8,500 per month from February 1, 2015 to June 30, 2015, then $10,000 per month from July 1, 2015 to December 31, 2015, and then $12,000 per month from January 1, 2016 to June 30, 2016. The end of the lease is currently June 2016. The total commitment on this lease for fiscal year 2016 is $132,000.

 

The Company moved to Shelton, Connecticut on April 21, 2015, to a facility with 15,000 square feet with monthly rent of $15,000, for a 7-year term with annual escalations of 3%. In December 2015 the Company committed to rent additional space in connection with the acquisition of the Dynamac proprietary line. In March 2016 the monthly rent becomes $18,400 and in August 2016 $24,740, The total commitment on this lease for fiscal year 2017 is approximately $290,000.

 

The Company has employment contracts with four executives with total annual salaries of $720,000 plus Company benefits. Two of the contracts are at will and two continue to February 2018. The Company also has a consulting contract with its General Manager for $192,000 per year plus certain benefits which continues until terminated by either party.

 

The Company leases 4 vehicles under operating leases expiring in 2016 through 2018. As of December 31, 2015 the future minimum rental payments for fiscal 2016 are $36,541.

 

  

We are subject to legal proceedings and other claims arising out of the conduct of our business, including proceedings and claims relating to commercial and financial transactions; government contracts and sub-contracts; alleged lack of compliance with applicable laws and regulations; production partners; product liability; patent and trademark infringement; employment disputes; and environmental, safety and health matters. Some potential legal proceedings and claims could seek damages, fines or penalties in substantial amounts or remediation of environmental contamination. As a government sub-contractor, we are subject to audits, reviews and investigations to determine whether our operations are being conducted in accordance with applicable regulatory requirements. Under federal government procurement regulations, certain claims brought by the U.S. Government could result in our suspension or debarment from U.S. Government contracting for a period of time. On the basis of information presently available, we do not believe that there are any existing proceedings or potential claims that would have a material effect on our financial position or results of operations.

 

On August 8, 2014, the Company signed a strategic partnership agreement with Dynamac, Inc. to develop, manufacture and market a portfolio of low cost RF/Microwave and Millimeter-wave calibrated test probes and related universal test platforms. The Company agreed to pay a one-time licensing and rights fee of $350,000 of which $50,000 was paid in the first quarter of fiscal 2015, and the remaining $300,000 was originally due in the second quarter.

 

On January 21, 2016, Microphase Instruments LLC, a wholly-owned subsidiary of Microphase Corporation (the “Company”) entered into a Purchase Agreement (the “Agreement”) with Dynamac, Inc. (the “Seller”), pursuant to which the Company acquired from the Seller that certain entire line of proprietary radio frequency (RF) and microwave test and measurement products, together with certain corresponding intellectual property, for an aggregate purchase price of $2,500,000 (the “Purchase Price”). The Purchase Price is payable in installments and late payments are subject to certain fees and interest payments.

 

The Agreement replaces all previous agreements and arrangements between by the Company and the Seller, including, without limitation, that certain strategic partnership agreement dated August 8, 2014.

  

  

ITEM 2. MANAGEMENT’S DISCUSSION OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS

 

This quarterly report on Form 10-Q and other reports filed by Microphase Corporation (the “Company”) from time to time with the SEC (collectively, the “Filings”) contain or may contain forward-looking statements and information that are based upon beliefs of, and information currently available to, the Company’s management as well as estimates and assumptions made by Company’s management. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. When used in the Filings, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these terms and similar expressions as they relate to the Company or the Company’s management identify forward-looking statements. Such statements reflect the current view of the Company with respect to future events and are subject to risks, uncertainties, assumptions, and other factors, including the risks relating to the Company’s business, industry, and the Company’s operations and results of operations. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned.

 

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

 

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments and assumptions. We believe that the estimates, judgments and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates and actual results. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting any available alternative would not produce a materially different result. The following discussion should be read in conjunction with our financial statements and notes thereto appearing elsewhere in this report.

 

RESULTS OF OPERATIONS OVERVIEW

 

Microphase Corporation designs and manufactures custom RF (radio frequency) and microwave products from DC to 40 GHz. Our products include components, subsystems and multi-function assemblies for the military and commercial markets. The Company has been in business for over 58 years and is one of the oldest and most established RF and microwave products companies in the industry.

 

The Company’s RF and microwave products enable the transmission, reception and processing of high frequency signals in defense electronics, homeland security systems and telecommunication networks. Our RF products are typically used in high frequency applications and include filters, switch filters, diplexers, multiplexers, detectors, detector logarithmic video amplifiers (DLVA) and multi-function assemblies. The end products in which the Company’s products are used include fighter planes, missiles, submarines, ships, drones, and IED jammers. Customers include Lockheed Martin, Raytheon, Saab, Rockwell Collins, L3 Communications and Northrup Grumman. Sales to the military markets comprised 100% of sales for 2014 and 2015.

 

Many years of deficit spending have caused U.S. Government budgets to come under significant pressure in recent years. In particular, the Budget Control Act of 2011 resulted in automatic spending reductions known as sequestration, through budget caps for both defense and non-defense spending. According to usgovernmentspending.com spending on Military Defense has gone from $693.5 billion in the government fiscal year 2010 (ending September 30) to $705.6 billion in 2011, $677.9 billion in 2012, $633.4 billion in 2013, $603.5 in 2014 and $597.5 in 2015. For the 2016 fiscal year military spending is showing a slight rebound at $615.5 billion. These multi-year decreases have had a significant negative impact on Microphase’s customers, with a resultant negative impact on Microphase’s results during and prior to the past three fiscal years.

 

The Company has been selling the same products to the same customers for many years. While every product order is manufactured to each customer’s specifications, the overall product offering has not changed. The Company believes it will need to introduce new products to the market in order to grow sales, in accordance with its strategy described in “Current Status and Management’s Plans.” The Company has been addressing its working capital shortage by raising additional debt from insiders, by executing private placements of common stock, and by its debt facility with Gerber Finance, Inc.

 

  

ACQUISITIONS

 

The Company is responding to the decrease in the defense budget by pursuing acquisitions of companies or product lines which are similar and/or related to existing product lines. In March of 2013 the Company acquired the assets of a DLVA manufacturing business in Folsom, California from Microsemi Corp. for $100,000 in cash plus a $650,000 note with payments through December 2014. That business, which we operate as a division and is referred to as “Microphase West”, contributed $1,120,624 in revenues and net operating losses of ($105,648) in the six months ended December 31, 2015 and $1,012,487 in revenues and net operating losses of ($6,061) in the six months ended December 31, 2014.

 

On July 9, 2014, the Company executed a securities purchase agreement with AmpliTech Group Inc. of Bohemia, N.Y. to purchase, as amended, 8,666,666 AmpliTech common shares at $0.023 per share for a total purchase price of $200,000. The purchase price was made up of two installments of $100,000.

 

On January 21, 2016, Microphase Instruments LLC, a wholly-owned subsidiary of Microphase Corporation (the “Company”) entered into a Purchase Agreement (the “Agreement”) with Dynamac, Inc. (the “Seller”), pursuant to which the Company acquired from the Seller that certain entire line of proprietary radio frequency (RF) and microwave test and measurement products, together with certain corresponding intellectual property, for an aggregate purchase price of $2,500,000 (the “Purchase Price”).

 

  

THREE MONTHS ENDED DECEMBER 31, 2015 VS. DECEMBER 31, 2014

 

Revenues.   Total revenues for the three months ended December 31, 2015 were $2,598,219, up from $1,849,895, in 2014, an increase of $748,324 or 40%. The revenue increase for the current period was primarily due an increase in sales to three major customers, and an increase in sales to a major foreign customer as a result of the restart of an existing program. The increase in sales to domestic customers was $502,342, and the increase to foreign customers was $245,982. The increase in sales is also partially due to the Company being able to purchase the parts necessary to complete and ship more orders resulting in more fluid production as compared to the period in 2014 when it was not able to source all the parts needed due to cash constraints, and as our backlog is reduced we do not expect a 40% year over year growth rate to continue as occurred in these comparable periods.

 

Cost of sales.   Cost of sales increased $208,885 for the three months ended December 31, 2015 from $1,138,463 in 2014 to $1,347,348, an increase of 18%. This increase in cost of sales is primarily due to the increase in revenues. The gross profit margin for the 2014 period was 38% and for 2015 was 48%. The improved gross margin was primarily due to an increase in sales of higher margin products and to lower overhead costs from the move from Norwalk to Shelton.

 

General and Administrative Expenses.   Selling, general and administrative expenses were $1,067,780 for the three months ended December 31, 2015 compared to $1,234,908 for the three months ended December 31, 2014, a decrease of $167,128 or 14%. SG&A expenses decreased primarily due a reduction in non-cash stock based compensation of $290,400 offset by increased expenses in connection with going public including D&O insurance premiums and investor relations and also due to increased compensation expense at Microphase West.

 

Engineering and Research Expenses.   Engineering and research expenses for the three months ended December 31, 2015 were down from $293,386 to $261,150 in the same period in 2014, a decrease of $32,236, or 11%. The decrease was due to the absence of a non-cash stock based compensation expense in the 2015 period versus $80,000 in 2014 offset by an increase in salaries primarily due to the addition of a senior engineer.

 

Non-operating Income (Loss).   Non-operating income (loss) was $(6,018) in the three months ended December 31, 2015 compared to $(1,232) in 2014 primarily due to approximately an $8,000 non-recurring fee paid in 2015 versus $0 in 2014.

 

Interest (Expense and Credit costs) net.   Interest expense and credit costs increased from $56,901 during the three months ended December 31, 2014 to $59,287 for the current period in 2015, an increase of $2,386. The higher interest costs in 2015 are primarily the result of the higher debt levels of the revolving credit lines.

 

Net (Loss) available to common shareholders.  The Company recorded net loss of $(182,681) for the three months ended December 31, 2015 as compared to a loss of ($1,758,760) for the same period ended December 31, 2014, an improvement of $1,576,079. The primary factor for this improvement is the increase in revenues and gross margin and a decrease in non-cash compensation and debt conversion costs, as well as the absence of a large non-cash preferred stock dividend in the 2015 period versus a $659,649 dividend recorded in the prior period. This represents basic loss per common share of $(0.04) in 2015 as compared to a loss per common share of $(0.45) in 2014, based upon basic & diluted weighted average common shares outstanding during the three month periods ending December 31, 2015 and December 31, 2014 of 4,935,433 and 3,930,679 respectively.

 

  

SIX MONTHS ENDED DECEMBER 31, 2015 VS. DECEMBER 31, 2014

 

Revenues.  Total revenues for the six months ended December 31, 2015 were $5,050,074, up from $3,779,078, in 2014, an increase of $1,270,996 or 34%. The revenue increase for the current period was due to an increase in revenues of $108,136, from Microphase West and an increase in revenues of $1,162,860, primarily due to two DLVA programs in Microphase East. The increase in sales to domestic customers was $933,178, and the increase to foreign customers was $337,818. The increase in sales is also partially due to the Company being able to purchase the parts necessary to complete and ship more orders resulting in more fluid production as compared to the period in 2014 when it was not able to source all the parts needed due to cash constraints, and as our backlog is reduced we do not expect a 34% year over year growth rate to continue as occurred in these comparable periods.

 

Cost of sales.  Cost of sales increased $519,013 for the six months ended December 31, 2015 from $2,243,518 in 2014 to $2,762,531, an increase of 23%. This increase in cost of sales is due to the increase in revenues. The gross profit margin for 2014 was 41% and for 2015 was 45%. This improvement reflects an increase in productivity from the volume increase and due to the mix of products and lower overhead costs from the move to the new facility in Shelton.

 

General and Administrative Expenses.  Selling, general and administrative expenses were $1,770,780 for the six months ended December 31, 2015 compared to $1,918,138 for the six months ended December 31, 2014, a decrease of $147,358 or 8%. The decrease in SG&A expenses in 2015 was due to a decrease in non-cash charges for stock grants of $294,600 offset by increases in salaries and professional fees of $147,242.

 

Engineering and Research Expenses.  Engineering and research expenses for the six months ended December 31, 2015 were $467,464 down from $500,629 in the same period in 2014, a decrease of $33,165, or 7%. Engineering and research expenses decreased in 2015 due to a decrease of $80,000 in non-cash charges for stock grants offset by increased salaries due to increased staffing due to the acquisition of the product line from Microsemi Corp. and the return of a senior engineer from an extended absence.

 

Non-operating Income (Loss).  Non-operating income (loss) decreased from $1,018 of income in the six months ended December 31, 2014 to a loss of $(3,768) in 2015. This includes the receipt of $2,275 of salvage proceeds from a vehicle previously leased in 2014.

 

Interest (Expense and Credit costs) net.  Interest expense and credit costs decreased from $119,589 during the six months ended December 31, 2014 to $117,458 for the current period in 2015, a decrease of $2,131. The lower interest expense and credit costs in 2015 reflect lower interest charges of $28,554 due to the lower debt levels of the debts other than the Gerber Facility, offset by increased fees and bank charges of $26,423.

 

Net (Loss) available to common shareholders.  The Company recorded net loss of $(112,294) for the six months ended December 31, 2015 as compared to a loss of ($1,885,543) for the same period ended December 31, 2014, an improvement of $1,773,249. The primary factor for this improvement is the increase in revenues and gross margin and a decrease in non-cash compensation and debt conversion costs, as well as the absence of a large non-cash preferred stock dividend in the 2015 period versus a $659,649 dividend recorded in the prior period.. This represents basic loss per common share of $(0.02) in 2015 as compared to a loss per common share of $(0.52) in 2014, based upon basic & diluted weighted average common shares outstanding during the three month periods ending December 31, 2015 and December 31, 2014 of 4,856,250 and 3,592,142 respectively.

 

  

LIQUIDITY AND CAPITAL RESOURCES

 

Through the six months ended December 31, 2015, the Company reported net loss of $112,294 and had cash and cash equivalents of $263,573. At December 31, 2015, we had an accumulated deficit of $12,967,514. At December 31, 2015, the Company had a working capital deficit of $939,136 as compared to a working capital deficit of $1,468,082 as of June 30, 2015, an improvement of $531,006 in the deficit. This improvement was primarily due to the reduction in accounts payable of $271,925 and the reduction in the current portion of Equity Lines of Credit of $314,338 as a result of renegotiating the guarantee of those lines. Our financial condition raises substantial doubt that we will be able to continue as a “going concern”, and our independent auditors included an explanatory paragraph regarding this uncertainty in their report on our financial statements as of June 30, 2015 when we had an accumulated deficit of $12,855,220 and a working capital deficit of $1,468,082.

 

During the six month period in 2015 the cash from operating activities was $76,841, primarily because the net loss of $(112,294) was offset by $335,400 of non-cash charges relating to stock compensation. Cash provided by operating activities was also increased due to depreciation and amortization of $46,710, to a decrease in inventory of $59,236, and to an increase in accrued expenses of $13,180. Cash provided by operating activities was reduced by an increase in accounts receivable of $131,638, a decrease in accounts payable of $128,075, and an increase in amounts due from related parties of $4,500.

 

During the six month period in 2014 the cash from operating activities was $104,696, primarily because the loss of $(1,225,894) was offset by $933,866 of non-cash charges relating to stock compensation, a reduction in accounts receivable of $321,835, depreciation and amortization of $44,929, a decrease in inventory of $5,805, a decrease in other currents asset of $47,202 and amounts due from related parties of $2,219, and an increase in accrued expenses of $92,248. Cash provided by operating activities was reduced by a decrease in accounts payable of $4,685, a decrease in amounts due to officers of $29,750, and a decrease in customer deposits of $89,634.

 

Cash (Used In) Investing Activities consisted of the purchase of $47,202 of fixed assets during the six month period in 2015 as compared to a $200,000 investment in Amplitech common stock, a $50,000 payment on the Dynamac co-venture and $2,275 in proceeds from asset sales during the six month period in 2014.

 

The Company has financed its operations in recent years primarily through a debt facility with a financial firm, loans from officers and related parties and several private placement offerings of its common stock to accredited investors.

 

During the six months ended December 31, 2015, the Company did not issue any shares of its common stock to investors in private placements. During the six months ended December 31, 2014, the Company issued 261,782 shares of its common stock to accredited investors in private placements of its common stock pursuant to Section 4(2) of the Securities Act of 1933, as amended, at $2.00 per share. The Company paid 68,782 shares to finders and received net proceeds of $354,550 after deducting $31,450 of cash costs, which was used for working capital.

 

The Company entered into a revolving credit facility with Gerber Finance, Inc. (“Gerber”) in 2012 with a maximum for this line, as amended, of $1,400,000. The outstanding balance as of December 31, 2015 was $1,179,800 and as of June 30, 2015 was $1,013,406. Under this agreement the Company receives funds based on a borrowing base which consists of various percentages of certain assets. The current interest rate is 7.25% and there is an annual facility fee of 1.75% plus monthly collateral monitoring fees of $1,500 and other fees.

 

Financing activities provided $106,841 during the six month period in 2015, primarily from the increased borrowings of $166,394 from our line from Gerber, reduced by debt service of $18,180 for our equity lines, $12,742 for long term debt, $5,264 capital leases and $3,986 for payments for the extended term arrangement and $18,381 payments to related parties. For the same period in 2014 financing activities used $(253,890) of our funds, which consisted primarily of $354,550 proceeds from private placements, discussed above, reduced by debt service of $3,576 for our equity lines, $925 for long term debt, $9,722 capital leases, $3,795 on payments for the extended term arrangement, $97,486 for related parties as well as $132,936 of payments on the Gerber line and a $360,000 pay down of acquisition notes.

 

  

CURRENT STATUS AND MANAGEMENT’S PLAN OF OPERATIONS

 

The Company has been seeking to diversify its market focus beyond its legacy products. By utilizing our current capability together with positioning ourselves through targeted acquisitions, strategic alliances and product partnering we believe we can augment our current product offerings and further enable us to continue to introduce a mix of new military and commercial products for the wireless telecom, autonomous auto, test & measurements, and medical instrumentation markets. This strategy should enable Microphase to broaden its customer base and reduce risk by spreading its revenue base across multiple market sectors. Targeted strategic acquisitions should increase our market share and the technology value of our product lines as well as broaden our product offering and diversify our customer base.

 

The Company anticipates that over the next eighteen months it will need between $2,000,000 and $5,000,000 of additional capital to implement its current plan of operations. This includes providing increased working capital for operations relating to our legacy products and funding the launch of our new subsidiary, Microphase Instruments, LLC, which will finalize the development of the initial test and measurement product line, and in turn manufacture and market our new portfolio of test products. We finalized our transaction agreement with Dynamac on January 21, 2016 whereby we acquired the proprietary line of low cost RF/Microwave and Millimeter-wave calibrated test probes and related universal test platforms together with certain corresponding intellectual property. We have continued to improve operations relating to our legacy products, which has resulted in increased sales volume and positive cash from operations in the current quarter. We may also need to issue shares of the Company’s common stock to maintain and fund the strategic alliances, product partnering and targeted acquisitions which the Company believes it can integrate efficiently. Having integrated the business that we acquired from Microsemi Corp., now known as Microphase West, we will also continue to develop and work on additional strategic opportunities.

 

The Company’s ability to continue as a going concern and its future success is dependent upon its ability to raise capital in the near term to: (1) satisfy its current obligations, (2) continue its research and development efforts, and (3) successfully continue the development, marketing and delivery of its products.

 

CRITICAL ACCOUNTING POLICIES, ESTIMATES AND ASSUMPTIONS

 

The SEC defines critical accounting policies as those that are, in management’s view, most important to the portrayal of our financial condition and results of operations and those that require significant judgments and estimates.

 

The discussion and analysis of our financial condition and results of operations is based upon our financial statements that have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities. On an on-going basis, we evaluate our estimates including the allowance for doubtful accounts, the salability and recoverability of inventory, income taxes and contingencies. We base our estimates on historical experience and on other assumptions that we believe to be reasonable under the circumstances, the results of which form our basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

We cannot predict what future laws and regulations might be passed that could have a material effect on our results of operations. We assess the impact of significant changes in laws and regulations on a regular basis and update the assumptions and estimates used to prepare our financial statements when we deem it necessary.

 

Allowance for Doubtful Accounts

 

The Company provides an allowance for doubtful accounts equal to the estimated uncollectible amounts. The Company’s estimate is based on historical collection experience and a review of the current status of Accounts Receivable. It is reasonably possible that the Company’s estimate of the allowance for doubtful accounts will change in the future.

 

Depreciation and Amortization

 

Property and equipment are recorded at cost. Depreciation is provided over the estimated useful lives of the related assets using the straight-line method for financial statement purposes. The Company uses other depreciation methods (generally, accelerated depreciation methods) for tax purposes where appropriate. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the remaining lease term or the estimated useful lives of the improvements.

 

  

Income Taxes

 

The Company accounts for income taxes under the provisions of Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) 740 “ Income Tax ”. ASC 740 requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial statement carrying amounts and tax bases of certain assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse. The deferred tax assets and liabilities are classified according to the financial statement classification of the assets and liabilities generating the differences. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has adopted the provisions of FASB ASC 740-10-05 “Accounting for Uncertainty in Income Taxes”. The ASC clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. The ASC prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The ASC provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

 

Inventory Obsolescence

 

Inventory quantities and related values are analyzed at the end of each fiscal quarter to determine those items that are slow moving or obsolete. An inventory reserve is recorded for those items determined to be slow moving with a corresponding charge to cost of goods sold. Inventory items that are determined obsolete are written off currently with a corresponding charge to cost of goods sold.

 

Revenue Recognition

 

Revenues and costs of revenues are recognized during the period in which the products are shipped. The Company applies the provisions of FASB Accounting Standards Codification (“ASC”) 605-10, Revenue Recognition in Financial Statements ASC 605-10, which provides guidance on the recognition, presentation, and disclosure of revenue in financial statements filed with the SEC. ASC 605-10 outlines the basic criteria that must be met to recognize revenue and provides guidance for disclosure related to revenue recognition policies. In general, the Company recognizes revenue for sale of products when (i) persuasive evidence of an arrangement exists, (ii) delivery has occurred, (iii) the fee is fixed or determinable, and (iv) the collectability is reasonably assured.

 

The Company’s sources of revenue are from the sale of various component amplifiers and filters. Revenue is recognized upon shipment of such products, FOB shipping point. The Company offers a 100% satisfaction guarantee against defects for 90 days after the sale of their product except for a few circumstances. There are no maintenance or service contracts related to any product sale.

 

OFF BALANCE SHEET TRANSACTIONS

 

As of February 16, 2016, we did not have any off-balance sheet arrangements.

 

  

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company is not exposed to changes in interest rates as the Company has no debt arrangements and no investments in certain held-to-maturity securities. Under our current policies, we do not use interest rate derivative instruments to manage exposure to interest rate changes. A hypothetical 100 basis point adverse move in interest rates along the entire interest rate yield curve would not materially affect the fair value of any financial instruments at December 31, 2015.

 

ITEM 4. CONTROLS AND PROCEDURES

 

(a) Evaluation of Disclosure Controls and Procedures.

 

Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rule 13a-15(b) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures are effective.

 

(b) Changes in Internal Control over Financial Reporting.

 

There were no changes in our internal control over financial reporting during the quarter ended December 31, 2015 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

We are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the executive officers of our company or any of our subsidiaries, threatened against or affecting our company, our common stock, any of our subsidiaries or of our companies or our subsidiaries’ officers or directors in their capacities as such, in which an adverse decision could have a material adverse effect.

 

ITEM 1A. RISK FACTORS.

 

We believe there are no changes that constitute material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the Fiscal Year Ended June 30, 2015, filed with the SEC on September 28, 2015.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

On December 16, 2015, Microphase Corporation (the “Company”) received a request to issue 770,733 shares of the Company’s common stock pursuant to the conversion of 11,561 shares of the Company’s Series A Convertible Preferred Stock (the “Preferred Stock”) held by RCKJ Trust. The issuance did not result in any proceeds to the Company as the conversion to common shares effectively cancelled 11,561 shares of Preferred Stock previously acquired by the holder.

 

During the three months ended December 31, 2015 the Company issued common shares to two consultants pursuant to consulting agreements and to two Officers and Directors for services, in the amounts of 80,000 and 70,000.

 

The above issuances were made in reliance on an exemption from registration set forth in Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Regulation D promulgated thereunder.

 

Compensatory Arrangements of Certain Officers

 

During the six months ended December 31, 2015, the Board of Directors approved and authorized changes to the compensation paid to James Ashman, the Company’s Chief Financial Officer and a Director of the Company, and Michael Ghadaksaz, the Company’s Chief Technology Officer, Chief Marketing Officer, and a Director of the Company. Mr. Ashman and Mr. Ghadaksaz will each receive equity interests in the Company pursuant to a schedule over the next four fiscal quarters. In accordance with such change in compensation, Mr. Ashman will receive an additional 100,000 shares of common stock as follows: 30,000 shares per quarter for the next three quarters, beginning December 31, 2015, and then 10,000 shares in the quarter ending September 30, 2016. Mr. Ashman also received an option to purchase 75,000 shares of common stock at $2.00 per share. Mr. Ghadaksaz will receive an additional 175,000 shares of common stock as follows: 40,000 shares per quarter for the next three quarters, beginning December 31, 2015, and then 55,000 in the quarter ending September 30, 2016.

 

  

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

There has been no default in the payment of principal, interest sinking or purchase fund installment, or any other material default, with respect to indebtedness of the Company.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

There is no other information required to be disclosed under this item which was not previously disclosed.

 

ITEM 6. EXHIBITS

 

EXHIBITS
10.1		Purchase Agreement - Acquisition of Dynamac’s Proprietary Line of RF and Microwave Test & Measurement Products, entered into January 21, 2016, by and between Microphase Instruments, LLC and Dynamac, Inc. (incorporated herein by reference to the Current Report on Form 8-K filed with the SEC on January 27, 2016)
31.1		Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes - Oxley Act of 2002.*
31.2		Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes - Oxley Act of 2002.*
32.1		Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.*
32.2		Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes - Oxley Act of 2002.*
101.INS		XBRL Instance Document*
101.SCH		XBRL Taxonomy Extension Schema Document*
101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF		XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB		XBRL Taxonomy Extension Label Linkbase Document*
101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document*

 

*

filed herewith.

 

  

SIGNATURES

 

Pursuant to the requirements of the Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant, has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

  

	MICROPHASE CORPORATION
Dated: February 16, 2016	By:	/s/ Necdet Ergul
	Name:	Necdet Ergul
	Title:	Chief Executive Officer (Principal Executive Officer)
	By:	/s/ James Ashman
	Name:	James Ashman
	Title:	Chief Financial Officer
		(Principal Financial Officer)
		(Principal Accounting Officer)